Public attitudes about pharmacogenomics / Mark A. Rothstein and Carlton A. Hornung -- Pharmacogenomics: pharmacology and toxicology in the genomics era / Harvey W. Mohrenweiser -- The implications of population genetics for pharmacogenomics / Craig L. Hanis -- Genome research and minorities / Henry T. Greely -- Drug development strategies / Penelope K. Manasco and Teresa E. Arledge -- Drug development, regulation, and genetically guided therapy / David W. Feigal and Steven I. Gutman -- Intellectual property and commercial aspects of pharmacogenomics / Allen C. Nunnally, Scott A. Brown, and Gary A. Cohen -- Integration of pharmacogenomics into medical practice / Gilbert S. Omenn and Arno G. Motulsky -- Clinical utility of pharmacogenetics and pharmacogenomics / Neil A. Holtzman -- Medical liability for pharmacogenomics -- Larry I. Palmer -- The challenges of pharmacogenomics for pharmacy education / David B. Brushwood -- Economic implications of pharmacogenomics / C.E. Reeder and W. Michael Dickson -- Pharmacogenomics and the social construction of identity / Morris W. Foster -- Pharmacogenomics: considerations for communities of color / Laurie Nsiah-Jefferson -- Constitutional issues in the use of pharmacogenomic variations associated with race / John A. Robertson

1. Pharmacogenomics
2. Pharmacogenetics
3. Drug Design
4. Ethics
5. Medical
6. Legislation
7. Medical
8. Public Policy
9. Social Environment
10. Electronic books.